Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stéphane Jouneau

Showing results (1-10 of 115) with videos related to

Pageof 12
Sort By:
Presse Medicale (Paris, France : 1983)|March 18, 2014
[Long-term macrolide treatment in adult chronic bronchial diseases: benefits and limits]Stéphane Jouneau, Benoît Desrues
Respirology (Carlton, Vic.)|May 5, 2020
Pulmonary alveolar proteinosisStéphane Jouneau, Cédric Ménard, Mathieu Lederlin
Current Opinion in Pulmonary Medicine|May 29, 2015
Repeated therapeutic thoracentesis to manage complicated parapneumonic effusionsStéphane Jouneau, Julien Letheulle, Benoit Desrues
Presse Medicale (Paris, France : 1983)|December 3, 2014
[Management of COPD exacerbations: from primary care to hospitalization]Stéphane Jouneau, Graziella Brinchault, Benoît Desrues
Transplantation Proceedings|January 10, 2022
Sirolimus-Induced Pulmonary Alveolar Proteinosis in the Context of Hematopoietic Stem Cells Transplant Rejection: A Case ReportLaura Marchasson, Julien Dutilh, Stéphane Jouneau, et al.
Drugs|August 27, 2025
Pharmacotherapy for Autoimmune Pulmonary Alveolar ProteinosisStéphane Jouneau, Pierre Chauvin, Mathieu Lederlin, et al.
European Journal of Internal Medicine|September 29, 2004
Vertebral osteomyelitis presenting as exudative pleural effusionStéphane Jouneau, Anne-Claire Volatron, Benoit Desrues, et al.
Revue De Pneumologie Clinique|September 6, 2005
[Pulmonary alveolar phospholipoproteinosis]Philippe Delaval, Graziella Brinchault, Romain Corre, et al.
Pulmonary Pharmacology & Therapeutics|August 2, 2022
Real-world safety profiles of pirfenidone and nintedanib in idiopathic pulmonary fibrosis patientsDorine Fournier, Stéphane Jouneau, Guillaume Bouzillé, et al.
International Immunopharmacology|April 12, 2019
Alteration of human macrophage phenotypes by the anti-fibrotic drug nintedanibNessrine Bellamri, Claudie Morzadec, Audrey Joannes, et al.
Pageof 12

Showing results (1-10 of 115) with videos related to

Sort By:
Pageof 12
Presse Medicale (Paris, France : 1983)|March 18, 2014
[Long-term macrolide treatment in adult chronic bronchial diseases: benefits and limits]Stéphane Jouneau, Benoît Desrues
Respirology (Carlton, Vic.)|May 5, 2020
Pulmonary alveolar proteinosisStéphane Jouneau, Cédric Ménard, Mathieu Lederlin
Current Opinion in Pulmonary Medicine|May 29, 2015
Repeated therapeutic thoracentesis to manage complicated parapneumonic effusionsStéphane Jouneau, Julien Letheulle, Benoit Desrues
Presse Medicale (Paris, France : 1983)|December 3, 2014
[Management of COPD exacerbations: from primary care to hospitalization]Stéphane Jouneau, Graziella Brinchault, Benoît Desrues
Transplantation Proceedings|January 10, 2022
Sirolimus-Induced Pulmonary Alveolar Proteinosis in the Context of Hematopoietic Stem Cells Transplant Rejection: A Case ReportLaura Marchasson, Julien Dutilh, Stéphane Jouneau, et al.
Drugs|August 27, 2025
Pharmacotherapy for Autoimmune Pulmonary Alveolar ProteinosisStéphane Jouneau, Pierre Chauvin, Mathieu Lederlin, et al.
European Journal of Internal Medicine|September 29, 2004
Vertebral osteomyelitis presenting as exudative pleural effusionStéphane Jouneau, Anne-Claire Volatron, Benoit Desrues, et al.
Revue De Pneumologie Clinique|September 6, 2005
[Pulmonary alveolar phospholipoproteinosis]Philippe Delaval, Graziella Brinchault, Romain Corre, et al.
Pulmonary Pharmacology & Therapeutics|August 2, 2022
Real-world safety profiles of pirfenidone and nintedanib in idiopathic pulmonary fibrosis patientsDorine Fournier, Stéphane Jouneau, Guillaume Bouzillé, et al.
International Immunopharmacology|April 12, 2019
Alteration of human macrophage phenotypes by the anti-fibrotic drug nintedanibNessrine Bellamri, Claudie Morzadec, Audrey Joannes, et al.
Pageof 12